SEC Form 4 · accession 0001104659-16-130152

SELECTA BIOSCIENCES INC · SELB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Carl L Gordon

Director · 10% Owner

Period of report

Jun 27, 2016

Accepted (ET)

Jun 29, 2016 · 4:49 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001453687

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F5	Jun 27, 2016	C	11,111	$0.00	A	12,193	I	See Footnote
Common Stock^F2,F5	Jun 27, 2016	C	1,166,884	$0.00	A	1,280,604	I	See Footnote
Common Stock^F1,F5	Jun 27, 2016	P	5,189	$14.00	A	17,382	I	See Footnote
Common Stock^F2,F5	Jun 27, 2016	P	544,811	$14.00	A	1,825,415	I	See Footnote

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	D/I
Series C Convertible Preferred Stock^F1,F5,F3	—	Jun 27, 2016	C	3,628	D	—	—	Common Stock	3,628	I
Series C Convertible Preferred Stock^F2,F5,F3	—	Jun 27, 2016	C	380,986	D	—	—	Common Stock	380,986	I
Series D Convertible Preferred Stock^F1,F5,F3	—	Jun 27, 2016	C	739	D	—	—	Common Stock	739	I
Series D Convertible Preferred Stock^F2,F5,F3	—	Jun 27, 2016	C	77,697	D	—	—	Common Stock	77,697	I
Series E Convertible Preferred Stock^F1,F5,F4	—	Jun 27, 2016	C	4,351	D	—	—	Common Stock	6,744	I
Series E Convertible Preferred Stock^F2,F5,F4	—	Jun 27, 2016	C	456,870	D	—	—	Common Stock	708,201	I

Explanation of responses

F1The reportable securities are owned directly by OrbiMed Associates III, LP ("Associates III"). OrbiMed Advisors LLC ("Advisors") is the general partner of Associates III. Samuel D. Isaly ("Isaly"), a natural person, is the managing member of and owner of a controlling interest in Advisors. By virtue of such relationships, Advisors and Isaly may be deemed to have voting and investment power over the securities held by Associates III and as a result may be deemed to have beneficial ownership over such securities. The Reporting Person is a member of Advisors.
F2The reportable securities are owned directly by OrbiMed Private Investments III, LP ("OPI III"). OrbiMed Capital GP III LLC ("GP III") is the general partner of OPI III, and Advisors is the managing member of GP III. Isaly is the managing member of and owner of a controlling interest in Advisors. By virtue of such relationships, GP III, Advisors and Isaly may be deemed to have voting and investment power over the securities held by OPI III and as a result may be deemed to have beneficial ownership over such securities.
F3The preferred stock is convertible at any time, at the holder's election and has no expiration date. The preferred stock automatically converted into common stock on a 1-for-1 basis upon the closing of the Issuer's initial public offering.
F4The Series E Convertible Preferred Stock is convertible at any time, at the holder's election and has no expiration date. The Series E Convertible Preferred Stock automatically converted into common stock on an approximately 1-for-1.550115 basis upon the closing of the Issuer's initial public offering.
F5Each of GP III, Advisors, Islay and the reporting person disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of GP III, Advisors, Islay, or the Reporting Person is a beneficial owner for the purpose of Section 16 of the Exchange Act, or for any other purpose.